Thor Medical ASA (OSL:TRMED)

Norway flag Norway · Delayed Price · Currency is NOK
2.600
+0.090 (3.59%)
Aug 15, 2025, 4:25 PM CET
160.00%
Market Cap 917.76M
Revenue (ttm) n/a
Net Income (ttm) -42.21M
Shares Out 352.99M
EPS (ttm) -0.18
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,696,930
Average Volume 937,534
Open 2.520
Previous Close 2.510
Day's Range 2.515 - 2.610
52-Week Range 0.956 - 4.990
Beta -0.14
RSI 64.62
Earnings Date Aug 29, 2025

About Thor Medical ASA

Thor Medical ASA produces and supplies alpha-particle emitters for cancer therapy in Norway. It develops Ra224, an isotope of radium; Pb-212, a radioactive isotope of lead; and Th-228, a radioactive isotope of thorium. The company was incorporated in 2009 and is headquartered in Oslo, Norway. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2009
Employees 9
Stock Exchange Oslo Børs
Ticker Symbol TRMED
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.